We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Implanted Pulley System Could Improve Postsurgical Hand Function

By HospiMedica International staff writers
Posted on 07 Oct 2014
A novel implanted passive engineering mechanism could improve hand function after tendon transfer surgery, according to a new study.

Researchers at Oregon State University (OSU; Corvallis, USA) and the University of Washington (Seattle, USA) conducted a cadaver study of a new tendon transfer surgical procedure that uses an implanted passive hierarchical artificial pulley mechanism for attaching multiple tendons to a single donor muscle, in place of directly suturing tendons to the muscle. More...
The purpose of the study was to evaluate hand function in physical interaction tasks, based on the actuation force required to create a grasp and the slippage between the fingers and the object after the grasp was created.

The tendon transfer surgery for high median ulnar palsy was used as an exemplar, where all four flexor digitorum profundus (FDP) tendons are directly sutured to the extensor carpi radialis longus (ECRL) muscle to restore flexion. The results showed that when compared with the suture-based procedure, the pulley-based procedure reduced the actuation force required to close all four fingers around the object by 45%, improved the fingers’ individual adaptation to the object’s shape during the grasping process, and reduced slippage by 52% after object contact. The study was published in the September 2014 issue of the journal Hand.

“This technology is definitely going to work, and it will merge artificial mechanisms with biological hand function,” said lead author Ravi Balasubramanian, PhD, an OSU expert in robotics, biomechanics and human control systems. “We'll still need a few years to develop biocompatible materials, coatings to prevent fibrosis, make other needed advances, and then test the systems in animals and humans. But working at first with hands – and then later with other damaged joints such as knees or ankles – we will help people recover the function they've lost due to illness or injury.”

The new mechanism is not really robotic since it has no sensory, electronic, or motor capabilities, but is rather a passive technology using a basic pulley implanted within a person's hand to allow more natural grasping function with less use of muscle energy.

Related Links:

Oregon State University
University of Washington



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Tourniquet System
heidi– mein Tourniquet
New
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The nasal spray is created using the ‘Nano-in-Micron’ technology platform. The micron-sized powder is inhaled and travels along the nose-to-brain pathway, bypassing the blood-brain barrier to deliver the drug directly to the brain (Photo courtesy of The University of Hong Kong

New Nasal Spray Enables Prehospital Neuroprotection in Ischemic Stroke

Ischemic stroke, caused by arterial occlusion in the brain, requires time‑critical intervention to limit neuronal loss. Many patients arrive outside the narrow window for thrombolysis or thrombectomy,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.